Epizyme to Participate in Upcoming Conferences in July
7/16/2012 9:51:37 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, today announced its participation in two upcoming conferences.
|